NPS ‐2143 inhibit glioma progression by suppressing autophagy through mediating AKT–mTOR pathway
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Jia-Li Nie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Affiliated Hospital of Guizhou Medical University, Guiyang, P.R. China. Hauptthemen laut MEDLINE: Glioma, Proto-Oncogene Proteins c-akt, Naphthalenes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guizhou Provincial Science and Technology Projects, National Natural Science Foundation of China, The Cultivate Project 2020 for National Natural Science Foundation of China, Affiliated Hospital of Guizhou Medical University.
Abstract (Originalsprache)
Gliomas are the most common tumours in the central nervous system. In the present study, we aimed to find a promising anti‐glioma compound and investigate the underlying molecular mechanism. Glioma cells were subjected to the 50 candidate compounds at a final concentration of 10 μM for 72 h, and CCK‐8 was used to evaluate their cytotoxicity. NPS‐2143, an antagonist of calcium‐sensing receptor (CASR), was selected for further study due to its potent cytotoxicity to glioma cells. Our results showed that NPS‐2143 could inhibit the proliferation of glioma cells and induce G1 phase cell cycle arrest. Meanwhile, NPS‐2143 could induce glioma cell apoptosis by increasing the caspase‐3/6/9 activity. NPS‐2143 impaired the immigration and invasion ability of glioma cells by regulating the epithelial–mesenchymal transition process. Mechanically, NPS‐2143 could inhibit autophagy by mediating the AKT–mTOR pathway. Bioinformatic analysis showed that the prognosis of glioma patients with low expression of CASR mRNA was better than those with high expression of CASR mRNA. Gene set enrichment analysis showed that CASR was associated with cell adhesion molecules and lysosomes in glioma. The nude mice xenograft model showed NPS‐2143 could suppress glioma growth in vivo. In conclusion, NPS‐2143 can suppress the glioma progression by inhibiting autophagy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Affiliated Hospital of Guizhou Medical University, Guiyang, P.R. China.
- College of Pharmacy, Guizhou Medical University, Guiyang, P.R. China.
- Centre of Clinical Trials, Affiliated Hospital of Guizhou Medical University, Guiyang, P.R. China.
- Clinical Research Center, Affiliated Hospital of Guizhou Medical University, Guiyang, P.R. China.
ORCID-Profile: Zhi-Peng Wen
Förderung
- Guizhou Provincial Science and Technology Projects
- National Natural Science Foundation of China
- The Cultivate Project 2020 for National Natural Science Foundation of China, Affiliated Hospital of Guizhou Medical University
Zitieren
APA
Nie, J. L., Li, Q., Yin, H. T., Yang, J. H., Li, M., Li, Q., Fan, X. H., Zhao, Q. Q., & Wen, Z. P. (2024). NPS ‐2143 inhibit glioma progression by suppressing autophagy through mediating AKT–mTOR pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18221
Vancouver
Nie JL, Li Q, Yin HT, Yang JH, Li M, Li Q, et al. NPS ‐2143 inhibit glioma progression by suppressing autophagy through mediating AKT–mTOR pathway. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18221
BibTeX
@article{Nie2024,
author = {Nie, Jia-Li and Li, Qi and Yin, Hai-Tang and Yang, Ji-Hong and Li, Ming and Li, Qin and Fan, Xing-Hua and Zhao, Qing-Qing and Wen, Zhi-Peng},
title = {NPS ‐2143 inhibit glioma progression by suppressing autophagy through mediating AKT–mTOR pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18221}
}
EUVIMED